Insight
Additional Considerations on IP Due Diligence for Prospective Investors of Emerging Life Sciences Companies
by Gargi Talukder, Jennifer Ng, Jessica Stern and Alex Straughn
December.15.2022

by Gargi Talukder, Jennifer Ng, Jessica Stern and Alex Straughn
December.15.2022
by Gargi Talukder, Jennifer Ng, Jessica Stern and Alex Straughn
December.01.2022
How the right level of IP due diligence can help inform investment decisions in the life sciences arena.
by Gargi Talukder, Jessica Stern, Alex Straughn and Jennifer Ng
June.22.2022